|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 380.50 TWD | -4.40% |
|
+7.49% | -22.03% |
| 25/05 | Bora Pharmaceuticals Co., Ltd., Q1 2026 Earnings Call, May 14, 2026 | |
| 13/05 | Bora Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Executive Committee: Bora Pharmaceuticals Co., LTD.
| Manager | Positions heldSince | ||||||
|---|---|---|---|---|---|---|---|
Pao Hsi Sheng |
| ||||||
Chin Chu Wang |
| ||||||
Raymond Lee |
| ||||||
Lynn Chuang |
|
Composition of the Board of Directors: Bora Pharmaceuticals Co., LTD.
| Director | CommitteesSince | ||||||
|---|---|---|---|---|---|---|---|
Pao Hsi Sheng |
| ||||||
Jui Yi Lin |
| ||||||
Shang Hung Shen 67 year |
| ||||||
Kuan Pai Chen |
| ||||||
Yi Chin Li |
| ||||||
Ming Jung Lai |
| ||||||
Shih Min Chen |
|
Latest Appointments: Bora Pharmaceuticals Co., LTD.
Former Officers and Directors: Bora Pharmaceuticals Co., LTD.
| Insider | Positions held SinceUntil | ||||||
|---|---|---|---|---|---|---|---|
| |||||||
| |||||||
| |||||||
| |||||||
| |||||||
| |||||||
|
Age distribution of managers
Parity Men Women
| Male | 8 |
|---|---|
| Female | 2 |
Of which Executive Committee
| Male | 2 |
|---|---|
| Female | 2 |
Of which Directors
| Male | 7 |
|---|---|
| Female | 0 |
Revisions
Recommandations analystes
-
Évolution recommandations analystes 1 an
-
Évolution recommandations analystes 4 mois
-
Objectif analystes
-
Évolution objectif analystes 1 an
-
Évolution objectif analystes 4 mois
-
ESG MSCI
ESG MSCI
Environnement
Social
Gouvernance
Polémique
Controverses Ethiques
No
Controverses sur les droits de l'Homme
No
Controverses Subventions fiscales
No
Conforme à la finance Islamique
No
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
















